Skip to main content
logo
BioArctic AB (publ) (STO:BIOA.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
308.80
-0.60 (-0.19%)
At close: Feb 27, 2026

BioArctic AB Revenue

In the year 2025, BioArctic AB had annual revenue of 2.00B SEK with 676.80% growth. BioArctic AB had revenue of 184.04M in the quarter ending December 31, 2025, with 81.79% growth.

Revenue
2.00B
Revenue Growth
+676.80%
P/S Ratio
13.69
Revenue / Employee
15.26M
Employees
131
Market Cap
27.37B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.00B1.74B676.80%
Dec 31, 2024257.35M-358.64M-58.22%
Dec 31, 2023616.00M386.56M168.49%
Dec 31, 2022229.43M203.77M794.02%
Dec 31, 202125.66M-39.54M-60.64%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Camurus AB2.27B
Saniona AB743.21M
Cantargia AB316.70M
BioInvent International AB244.85M
Hansa Biopharma AB222.27M
Genovis AB (publ.)129.65M
Egetis Therapeutics AB62.40M
Vicore Pharma Holding AB8.50M
Revenue Rankings

BioArctic AB News

More News